scholarly article | Q13442814 |
P50 | author | Shixuan Wang | Q87002130 |
Juncheng Wei | Q123029446 | ||
Liangpin Zhao | Q123029469 | ||
P2093 | author name string | Gang Chen | |
Gang Xu | |||
Tao Zhu | |||
Ping Liu | |||
Ding Ma | |||
Jianfeng Zhou | |||
Li Meng | |||
Yunping Lu | |||
Qiong Li | |||
Zhiqiang Han | |||
Mingfu Wu | |||
Anping Song | |||
Yongtao Zhang | |||
P433 | issue | 1A | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
tumor invasion | Q60750433 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 327-334 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Anticancer Research | Q326290 |
P1476 | title | Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation | |
P478 | volume | 28 |
Q35020469 | 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway |
Q26799171 | A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition |
Q35357838 | A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells |
Q33654771 | A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis |
Q64988893 | Association of low expression of E-cadherin and β-catenin with the progression of early stage human squamous cervical cancer. |
Q91891314 | Bacterial type III effector protein HopQ inhibits melanoma motility through autophagic degradation of vimentin |
Q37174010 | CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. |
Q34984681 | CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells |
Q27305106 | Cells activated for wound repair have the potential to direct collective invasion of an epithelium |
Q28535408 | DNA-PK target identification reveals novel links between DNA repair signaling and cytoskeletal regulation |
Q35739519 | Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone. |
Q33430245 | Differential tissue-specific protein markers of vaginal carcinoma |
Q92857993 | Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer |
Q35190722 | EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis |
Q64078745 | Effect of Weightlessness on the 3D Structure Formation and Physiologic Function of Human Cancer Cells |
Q37424118 | Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells |
Q40878152 | Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer |
Q34817706 | Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? |
Q45867047 | Fibroblast and prostate tumor cell cross-talk: Fibroblast differentiation, TGF-β, and extracellular matrix down-regulation |
Q55519861 | Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer. |
Q33591231 | Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics |
Q36144155 | Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomics |
Q33567647 | Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma |
Q26865818 | Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function |
Q64055855 | LncRNA H19 interacted with miR-130a-3p and miR-17-5p to modify radio-resistance and chemo-sensitivity of cardiac carcinoma cells |
Q36320084 | Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner |
Q27693294 | Networking galore: intermediate filaments and cell migration |
Q92696902 | Prognostic significance and biological function of Lamina-associated polypeptide 2 in non-small-cell lung cancer |
Q33940201 | Proteomic patterns of cervical cancer cell lines, a network perspective |
Q37770437 | Proteomic strategies and challenges in tumor metastasis research. |
Q41243003 | Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma through p38 MAPK Pathway |
Q37609793 | Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer |
Q36738790 | Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? |
Q42609690 | S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells |
Q27012541 | SRC: marker or actor in prostate cancer aggressiveness |
Q38885517 | SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells |
Q37675705 | Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression |
Q51735633 | Site-specific glycosylation regulates the form and function of the intermediate filament cytoskeleton. |
Q33648775 | TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells |
Q97520547 | The Expressions and Mechanisms of Sarcomeric Proteins in Cancers |
Q52714409 | The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer. |
Q38259961 | The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer. |
Q41582512 | The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma |
Q37771259 | The dual kinase complex FAK-Src as a promising therapeutic target in cancer |
Q38712604 | The role of microRNAs in prostate cancer progression |
Q42378305 | Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis. |
Q42105757 | Vimentin Levels and Serine 71 Phosphorylation in the Control of Cell-Matrix Adhesions, Migration Speed, and Shape of Transformed Human Fibroblasts |
Q90384644 | Vimentin Plays a Crucial Role in Fibroblast Ageing by Regulating Biophysical Properties and Cell Migration |
Q35182104 | Vimentin in cancer and its potential as a molecular target for cancer therapy |
Q33868704 | Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition |
Q64076917 | Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury |
Q37711551 | Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA. |
Q41046247 | Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice |
Q34577302 | Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity |
Q27305726 | Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition |
Q37317545 | c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC |
Q47715195 | p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. |
Search more.